Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

12.90 +0.12 (+0.98%)
Streaming Delayed Price Updated: 2:00 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
20 21 Next >
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
From Teva Pharmaceutical Industries Limited
Via Business Wire
Most Active Equity Options For Midday - Wednesday, Jan. 11
Here are the most active equity options for midday. 
Via Talk Markets
NVAX Stock Alert: What to Know as Novavax Names New CEO
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries. 
Via InvestorPlace
Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States
From Teva Pharmaceutical Industries Limited
Via Business Wire
4 Analysts Have This to Say About Teva Pharmaceutical Indus
Via Benzinga
Analyst Ratings for Teva Pharmaceutical Indus
Via Benzinga
4 Stocks That Actually Increased in 2022 -- And They're Still Worth Buying Now
These all handily outperformed the market last year and could do the same in 2023. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
From Teva Pharmaceutical Industries Limited
Via Business Wire
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
From Alvotech
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
Via Benzinga
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
2023 Kick-Off With Apple Losing $2T With Big Option Trades On GLD And XLE
While the tenor was more bearish, the late-day rally found the market close to where it finished 2022. 
Via Talk Markets
Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Teva Pharmaceutical Industries Limited
Via Business Wire
2 "Safe" Stocks That Are Anything But
Sometimes, business models that sound safe still fail to deliver for shareholders. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®
From Alvotech
Via GlobeNewswire
My Top 5 Portfolio Holdings for 2023
This mix of growth and value stocks can outperform in a challenging environment. 
Via The Motley Fool
Looking At Teva Pharmaceutical Indus's Recent Unusual Options Activity
Someone with a lot of money to spend has taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the big position showed up on... 
Via Benzinga
Is Prometheus Biosciences a Good Stock to Buy Right Now?
This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead. 
Via The Motley Fool
3 Unparalleled Stocks to Buy That Have Never Been This Cheap
These three leading companies are ripe for the picking and may never be this cheap again. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to... 
Via Benzinga
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
Via Benzinga
Stocks Move Higher As Wall Street Eyes China Lockdowns
The Dow Jones Industrial Average is up 271 points midday, while the Nasdaq Composite and S&P 500 Index are firmly higher as well. 
Via Talk Markets
Teva Finalizes Nationwide Opioid Settlement Terms
From Teva Pharmaceutical Industries Limited
Via Business Wire
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share. 
Via InvestorPlace
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO. 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.